Skip to main content
OpenTrials
Completed

NCT Number: NCT06106373

iotaSOFT Pediatric Study

Prospective, non-randomized, open-label study to evaluate the safety and efficacy of the iotaSOFT Insertion System when used to assist electrode array insertion during cochlear implant surgery in a pediatric population.

Completed

Looking for future studies?

Notify Me

Key information

Age range

9 month–12 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

University of Iowa, Iowa City, Iowa, United States

Loading trial locations.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Candidate for unilateral or bilateral cochlear implantation according to indications for use with FDA approved cochlear implant devices
  • Age 9 months to less than 12 years old at the time of CI surgery
  • Willingness to participate in the study and able to comply with the follow-up visit requirements

Exclusion criteria

  • Prior cochlear implantation in the ear to be implanted
  • Ossification or any other cochlear anomaly that might prevent complete insertion of the electrode array or present an increased risk of aberrant insertion
  • Craniofacial abnormality, temporal squamosal skull thickness less than 3mm, major cochlear lesions, or cochlear malformations
  • Deafness due to lesions of the acoustic nerve or central auditory pathway
  • Diagnosis of auditory neuropathy.
  • Active middle-ear infection or tympanic membrane perforation in the presence of active middle-ear disease
  • Absence of cochlear development
  • Additional medical concerns that would prevent participation in evaluations as determined by the investigator
  • Planned or current participation in a clinical study of an investigational device or drug

Treatment and study plan

iotaSOFT Insertion System

Device

robotic assistive technology for cochlear implant electrode insertion

Primary outcomes

  1. Safety related to adverse events

    Time frame: 30 days following surgery

    Evaluation of iotaSOFT related adverse events and serious adverse events through 30 days after surgery

Sponsors and collaborators

Lead sponsor

iotaMotion, Inc.

Industry

Registry information

Official study title

iotaSOFT Insertion System for Use With Cochlear Implant Surgery in Pediatrics

Important dates

Study start
2022
Primary completion
2024
Study completion
2025
First posted
Oct 30, 2023
Registry last updated
Sep 15, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.